Labarai

RD13-02 samfurin ƙwayoyin CAR-T ne na duniya wanda ke nufin CD7 wanda aka samo daga masu ba da gudummawa masu lafiya, kuma an yi shi ne don maganin cutar sankarar lymphoblastic mai saurin kamuwa da cutar T-cell (T-ALL/LBL) wadda ta sake dawowa ko kuma ta sake yin illa. Ana gyara ta ta hanyar kwayoyin halitta don guje wa cutar fratricide, cutar graft-versus-host (GvHD), da kuma cutar host-versus-...Kara karantawa»

CT011 samfurin ƙwayoyin GPC3 CAR T ne mai zaman kansa wanda ake nema don maganin cutar kansar hanta (HCC). CT011 ya sami izinin IND daga NMPA a shekarar 2019 don maganin marasa lafiya da ke da ciwon daji mai kyau na GPC3 wanda shine gwajin IND na farko da China ta yi don maganin ƙwayoyin T na CAR akan ƙwayoyin halitta masu ƙarfi ...Kara karantawa»

Wani farfesa a jami'ar Rasha a ƙarshen shekarunsa na saba'in yana fama da cutar myeloma mai tsanani. Bayan ya yi jiyya da dama da kuma sake dawowa dashen kansa sau biyu, ya sami labarin maganin CAR-T na zamani a China, don haka ya zo China don karɓar ƙwayoyin CAR-T a wurin...Kara karantawa»

A ranar 20 ga Yuli, Hukumar Kayayyakin Lafiya ta Kasa ta China (NMPA) ta amince da amfani da sabon magani (NDA) na pCAR-19B wanda aka ƙirƙiro da kansa ta hanyar Precision Biology. Wannan samfurin shine samfurin CAR-T na farko don cutar sankarar bargo ta yara a China, wanda ake amfani da shi don magance marasa lafiya masu shekaru 3-21 ...Kara karantawa»

satricabtagene autoleucel（Satri-cel,CT041) wani samfurin ƙwayoyin T-cell ne na CAR wanda ke da ikon zama na farko a duniya. Satri-cel yana kai hari ga ƙwayoyin cuta masu ƙarfi na Claudin18.2 tare da mayar da hankali kan cutar kansar ciki/cutar haɗin gastroesophageal...Kara karantawa»

A ranar 6 ga Satumba, 2021, JW Therapeutics ta sanar da cewa Hukumar Kayayyakin Lafiya ta Kasa (NMPA) ta kasar Sin ta amince da amfani da Sabon Maganin Magani (NDA) don maganin rigakafi na kwayoyin halittar CAR-T da ke hana CD19 autologous chimeric antigen receptor T (CAR-T) relmacabtagene autoleucel allura (relma-cel) ...Kara karantawa»

Equecabtagene autoleucel (eque-cel), wani maganin T-cell na maturation antigen-targeting chimeric antigen receptor (CAR) wanda aka samo daga ɗan adam, ya nuna yuwuwar maganin sake dawowa ko rashin ƙarfin myeloma mai yawa (R/RMM). A ranar 30 ga Yuni, 2023, Kayayyakin Lafiya na Ƙasa na China Sun Ba da Shawara...Kara karantawa»

A ranar 11 ga Oktoba, 2024, Hukumar Kula da Kayayyakin Lafiya ta Kasa (NMPA) ta amince da aikace-aikacen Investigational New Drug(IND) don Inaticabtagene Autoleucel (CNCT19 Allura), wani maganin CD19 mai ɗauke da autologous chimeric antigen receptor (CAR)-T cell, don magance thrombocytopenia na garkuwar jiki ...Kara karantawa»

A ranar 1 ga Maris, 2024, Hukumar Kayayyakin Lafiya ta Ƙasa ta China (NMPA) ta amince da ƙaddamar da samfurin ƙwayoyin CAR-T Zevorcabtagene AutoLeucel (Zevor-cel, CT053) don maganin manya marasa lafiya da suka sake kamuwa da cutar myeloma mai yawa waɗanda suka ci gaba bayan aƙalla layuka 3 na magani (...Kara karantawa»

Clustered akai-akai interspaced short palindromic repeats (CRISPR) wata dabara ce ta gyaran kwayoyin halitta ta ƙarni na uku wadda ta kawo sauyi a duniya tare da sakamakonta mai yawa. An yi amfani da ita don magance cututtuka daban-daban na halitta da cututtuka. Kwayoyin cuta daban-daban...Kara karantawa»

Shari'a ta 1: Majinyacin namiji mai shekaru 69 ya je asibiti don a duba shi saboda ciwon ƙirji. Abin takaici, ya kamu da cutar kansar ƙwayoyin squamous cell mai ƙarancin bambanci a cikin huhun sama na dama. Majinyacin bai iya jure wa tiyata ba. Bayan shawarwarin ƙwararru, cryoablation shine mafi kyawun mafita kuma...Kara karantawa»

Cryoablation: "Labari mai daɗi" ga marasa lafiya da ke fama da ciwon daji a sassa daban-daban na jiki Shahararren tauraron fina-finan Hong Kong Wu MengDa ya mutu sakamakon ciwon daji na hanta, tafiyar Uncle Da ta sa mutane da yawa suka yi nadama. "Ciwon daji na hanta" an san shi da sarkin ciwon daji, kuma kashi 70% na hanta ...Kara karantawa»